Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Adrenocortical Carcinoma × pembrolizumab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 4 OTHER_GOV 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Ovarian Neoplasms 2 Melanoma 2 Head and Neck Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Uveal Melanoma 1 Urogenital Neoplasms 1 Thymoma 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcopenia 1 Recurrence 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Diseases 1 Neoplasms, Glandular and Epithelial 1 Gliosarcoma 1 Glioblastoma 1 Genital Neoplasms, Female 1 Endometrial Neoplasms 1 Efficacy, Team 1 Carcinoma, Ovarian Epithelial 1 Advanced Solid Tumours 1 Advanced Solid Tumor 1 Adrenocortical Carcinoma 1

Interventions

pembrolizumab 1 lenvatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05036434 2026-01-23

ACCOMPLISH

National Cancer Center, Korea

Phase 2 Active not recruiting

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡